Glucose‐lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 554-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK

By Lloyd A.   Townsend C.   Munro V.   Twena N.   Nielsen S.   Holman A.  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 599-605

Informa Healthcare

Access to resources Recommend Favorite

Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 3, 2015-05 ,pp. : 164-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin degludec/insulin aspart produces a dose‐proportional glucose‐lowering effect in subjects with type 1 diabetes mellitus

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 659-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study

By Palmer James L.   Goodall Gordon   Nielsen Steffen   Kotchie Robert W.   Valentine William J.   Palmer Andrew J.   Roze Stéphane  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1417-1428

Informa Healthcare

Access to resources Recommend Favorite